We’re pleased to announce a strategic partnership 🤝 with Google Cloud. In line with our digital transformation, this agreement is centered around the use of data and artificial intelligence and aims to increase our innovation capabilities to serve patient needs. Google Cloud will provide us with the use of cloud storage spaces, as well as innovative tools with exceptional computing power and the possibility to accelerate data analysis and understanding through the use of AI. As Virginie Dominguez, Executive Vice President Digital, Data and Information Systems, stated: 🗣️ “Data and artificial intelligence are opening up tremendous prospects for drug discovery, disease prevention, and improved treatment adherence across the entire pharmaceutical value chain. ”
We invest over 50% of our R&D budget in #oncology. Our research is focused on hard-to-treat cancers to address high unmet medical needs among patients. Listen to Des Murphy Head of Global Medical & Patient Affairs Oncology, describe our commitments to patients.
Today is World Humanitarian Day! 🤝 Mécénat Servier is involved with NGOs, such as La Chaîne de l'Espoir, which works to strengthen the health system for children, and TECHO, which helps families in extreme poverty. Thanks to Servier's support, 20 homes and several eco-toilets have been built with TECHO . The program supported by Mécénat Servier and its volunteers includes the construction of 34 emergency houses, two eco-toilets and a community center in several Latin American countries. Last year, more than 50 children underwent surgery at the Cuomo Pediatric Cardiology Center in Dakar thanks to the collaboration between Mécénat Servier and La Chaîne de l'Espoir. This partnership also encourages strengthening the skills of the center's medical and paramedical teams in order to ensure quality care. Join us for a healthier future! 🌍
We’re thrilled to share that we officially opened our new R&D Center in the Seaport of Boston, MA – the epicenter of scientific innovation and development. This space further strengthens and expands our oncology presence in the U.S. market, fueling the next generation of scientific discovery. Our CEO and Chairman, Olivier Laureau spoke with Fierce Biotech about what this expansion means for Servier.
For several years, we have been committed to treating Chronic Venous Disease and hemorrhoidal disease, partnering with healthcare professionals 👩⚕️🧑⚕️. Venous disease is one of the most common diseases in the developed world, affecting up to 60% of adults over the age of 50. This July, we’re back 🚀🔥 with a new season of our awareness campaign.
🌍 Today is World Environment Day! This year, we are joining the United Nations Environment Programme's (UNEP) global campaign: "Only One Earth". At Servier, our trajectory to reduce our carbon footprint by 25% by 2030 has been approved by SBTi. This includes reduction targets to: ✅ conserve natural resources ✅ fight global warming ✅ protect biodiversity
👋 Our CSR strategy focuses on our major stakeholders: patients, employees, partners, the environment, territories, and communities. It is organized into 5 programs covering the eco-design of products, diversity and inclusion, employee safety, responsible partnership, and the fight against climate change. 📖 See how our CSR strategy has evolved since 2016, as well as key performance indicators 👉
[#WomenInScience 👩🔬] Today is International Day of Women and Girls in Science! Join us and support the United Nations’ campaign to promote full and equal access and participation for women and girls in science ⚗️. Thank you to Sofia Lotfi, Iffat Sumia, Christiane HENNION, and Agnes DEVOIS, MD for your inspirational testimonials 🗣️👇
👇📽️ Watch the highlights of the 2nd edition of the Servier Diversity & Inclusion week. The objective 🎯 : Open up the Conversation! Teams from across the Group came together for sharing experiences and best practices, listening to experts and learning more about Servier’s initiatives to promote a more diverse and inclusive workplace🔥🚀. 💪 Thanks to #ServierRussia 🇷🇺 , Servier do Brasil 🇧🇷 , Servier France 🇫🇷 , Servier Pharmaceuticals 🇺🇸 for sharing your inspiring actions. 💪 Thanks to Pete Stone (he/his), D&I Expert and Founder at Just Different for your insightful talk. Check out more about our commitment 👉 https://bit.ly/33OdiL8
🗣️ We are proud to announce that for the 2nd consecutive year we’ve been certified as 🌟 Top Employer Europe 2022! 6 Group subsidiaries received Top Employer certification in their respective countries: Belgium, France, Greece, Italy, Portugal and Spain. We are truly honored by this recognition of our HR practices and our commitment to creating a great workplace for our #employees.
